About Noblegen
Noblegen is a company based in Peterborough (Canada) founded in 2013 was acquired by SolarBiotech in July 2023. It operates as a Commission-Based. Noblegen has raised $18.51 million across 3 funding rounds from investors including HHS and SolarBiotech. Noblegen offers products and services including Online Slots. Noblegen operates in a competitive market with competitors including Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others.
- Headquarter Peterborough, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.51 M (USD)
in 3 rounds
-
Latest Funding Round
$18.51 M (USD), Series B
May 30, 2019
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
-
Acquired by
SolarBiotech
(Jul 25, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Noblegen
Noblegen offers a comprehensive portfolio of products and services, including Online Slots. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Online slots are provided with easy winning opportunities.
Unlock access to complete
Funding Insights of Noblegen
Noblegen has successfully raised a total of $18.51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $18.51 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $18.5M
-
First Round
First Round
(19 Sep 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series B - Noblegen | Valuation |
investors |
|
| Jun, 2016 | Amount | Series A - Noblegen | Valuation |
investors |
|
| Sep, 2013 | Amount | Grant - Noblegen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Noblegen
Noblegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and SolarBiotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Modular plant architectures are produced for scaling laboratory equipment.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Noblegen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Noblegen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Noblegen Comparisons
Competitors of Noblegen
Noblegen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Microbiome therapeutics are developed to address diverse diseases.
|
|
| domain | founded_year | HQ Location |
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
|
|
| domain | founded_year | HQ Location |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Noblegen
Frequently Asked Questions about Noblegen
When was Noblegen founded?
Noblegen was founded in 2013.
Where is Noblegen located?
Noblegen is headquartered in Peterborough, Canada. It is registered at Peterborough, Ontario, Canada.
Is Noblegen a funded company?
Noblegen is a funded company, having raised a total of $18.51M across 3 funding rounds to date. The company's 1st funding round was a Grant of $272.22K, raised on Sep 19, 2013.
What does Noblegen do?
Noblegen is managed as a direct online slots platform offering gaming services without intermediaries. It is focused on the online gambling sector, providing a variety of slot games with high payout rates and bonuses. Solutions include seamless deposit and withdrawal systems using True Wallet, ensuring accessibility even for users with minimal capital. The platform is supported by a certified API system for transparency and security, catering to a wide range of players seeking entertainment and real money rewards.
Who are the top competitors of Noblegen?
Noblegen's top competitors include Novozymes, Seres Therapeutics and Seed.
What products or services does Noblegen offer?
Noblegen offers Online Slots.
Who are Noblegen's investors?
Noblegen has 2 investors. Key investors include HHS, and SolarBiotech.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.